Johan M Kros

17PUBLICATIONS
113CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer geneticsMedical virologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 02, 2026
Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

|Jan 03, 2025
ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip.

John J Y Lee, Ran Tao, Zhen You

|Jul 11, 2024
Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study.

Thijs van der Vaart, Maarten M J Wijnenga, Karin van Garderen

|Feb 17, 2024
Association of blood cell-based inflammatory markers with gut microbiota and cancer incidence in the Rotterdam study.

Shiva Najjary, Johan M Kros, Bruno H Stricker

|Jan 11, 2024
MRI-Based Assessment of Brain Tumor Hypoxia: Correlation with Histology.

Fatemeh Arzanforoosh, Maaike Van der Velden, Avery J L Berman

|Nov 29, 2023
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.

Karin A van Garderen, Wies R Vallentgoed, Anna Lavrova

Pageof 3

Frequent Collaborators

7 joint publications

Martin Van den Bent

6 joint publications

Pim J French

4 joint publications

Marion Smits

3 joint publications

Michael Weller